FDAHealthAugust 22, 2024
ProRx LLC — Tirzepatide 2 mL (10 mg/mL) and 20 mg/mL, 2mL Multidose SC Injection vials, Compounded Rx Product, ProRx 267-565-7008, NDC 84139-210-01
⚠️ Lack of Assurance of Sterility
Is this relevant to me?
- Geography
- Nationwide
- Source agency
- FDA
- Category
- Health
- Published
- August 22, 2024
Nationwide in the USA
What's affected?
- Product
- Tirzepatide 2 mL (10 mg/mL) and 20 mg/mL, 2mL Multidose SC Injection vials, Compounded Rx Product, ProRx 267-565-7008, NDC 84139-210-01
- Brand
- ProRx LLC
- Lot code
- ProRx040924-1
Additional details
Lot # ProRx040924-1, BUD 10/08/2024
What should I do?
Recommended action
Class II recall. Voluntary: Firm initiated Quantity affected: 37 vials.
Get Health recall alerts
Delivered to your inbox. Free. No account required.